BACE1 and Alzheimer disease: Park et al. (2019) reported that the expression of BACE1 has been successfully reduced by employing Cas9 nanocomplexes, which was prepared by adding amphiphilic R7L10 peptide to Cas9-sgRNA, in two mouse models of AD.